Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients

بواسطة Lee, H.S., Fan, L., Khoo, Y.M., Goh, B.C., Wang, L., Lim, R., Ong, A.B., Chua, C.
منشور في 2012

Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients

بواسطة Lee, H.S., Goh, B.C., Fan, L., Khoo, Y.M., Wang, L., Lim, R., Ong, A.B., Chua, C.
منشور في 2014

Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma

بواسطة Chuah, B., Lim, R., Boyer, M., Ong, A.-B., Wong, S.-W., Kong, H.-L., Millward, M., Clarke, S., Goh, B.-C.
منشور في 2016

Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug

بواسطة Tham, L.-S., Lee, H.-S., Wang, L., Yong, W.-P., Fan, L., Ong, A.-B., Sukri, N., Soo, R., Lee, S.-C., Goh, B.-C.
منشور في 2014

Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies

بواسطة Goh, B.-C., Lee, S.-C., Wang, L.-Z., Fan, L., Guo, J.-Y., Lamba, J., Schuetz, E., Lim, R., Lim, H.-L., Ong, A.-B., Lee, H.-S.
منشور في 2014

A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy

بواسطة Koh, T.S., Thng, C.H., Hartono, S., Tai, B.C., Rumpel, H., Ong, A.B., Sukri, N., Soo, R.A., Wong, C.I., Low, A.S.C., Humerickhouse, R.A., Goh, B.C.
منشور في 2014